The COVID-19 pandemic has left a lasting impact on millions worldwide, with many individuals experiencing long-term symptoms, collectively known as “long COVID.” Among these persistent issues, the loss or distortion of the sense of smell, medically termed anosmia, has significantly affected the quality of life for countless sufferers. Recent advancements in surgical interventions, however, offer a beacon of hope for those enduring this challenging condition.​

Understanding Anosmia in Long COVID

Anosmia refers to the partial or complete loss of the sense of smell. During the acute phase of COVID-19, many patients reported anosmia as a common symptom. While some regained their olfactory functions within weeks, others continued to experience diminished or absent smell for months, leading to challenges in daily activities, nutrition, and overall well-being.​

The Surgical Intervention: Functional Septorhinoplasty (fSRP)

Researchers at University College London Hospitals (UCLH) have explored the efficacy of functional septorhinoplasty (fSRP) in treating long COVID-related anosmia. Traditionally, fSRP is performed to correct deviations in the nasal septum, enhancing airflow and addressing structural nasal issues. In the context of long COVID, the surgery aims to improve airflow to the olfactory region, potentially “kick-starting” the recovery of the sense of smell.​

Clinical Trial Insights

A recent study involving 25 long COVID patients provided valuable insights into the potential benefits of fSRP:​

  • Participants: Twelve patients underwent the fSRP surgery, while a control group of thirteen continued with traditional smell training exercises, which involve repeated exposure to specific scents to stimulate olfactory recovery.​

  • Outcomes: All patients who received the surgical intervention reported an improved sense of smell. In contrast, none of the patients in the control group experienced improvement; notably, 40% reported a worsening of their olfactory function.​

These findings suggest that fSRP may offer a viable treatment option for those suffering from long-term anosmia due to COVID-19.​

Patient Perspective: A Return to Normalcy

For individuals like Penelope Newman, 27, from South London, the surgery has been life-changing. After losing her sense of smell post-COVID-19, Penelope faced numerous challenges, from limited food choices to social isolation. Post-surgery, she reported a significant improvement, stating that her taste and smell have “almost returned to normal,” allowing her to enjoy cooking, dining out, and reconnecting with loved ones.​

The Broader Implications

With estimates suggesting that up to 100,000 people in the UK alone may be experiencing COVID-19-related anosmia, the potential of surgical interventions like fSRP offers hope. Restoring the sense of smell can significantly enhance the quality of life, mental health, and daily functioning of affected individuals.​

Conclusion

The exploration of surgical options such as functional septorhinoplasty marks a promising development in addressing long-term anosmia in COVID-19 survivors. As research progresses, such interventions may become standard practice, offering relief to those whose senses have been dulled by the pandemic’s lingering effects.

Seeking Specialist Care at London ENT

If you are experiencing long-term loss or distortion of your sense of smell following COVID-19, consulting an ENT specialist could be the next step in your recovery. At London ENT, our experienced team provides expert diagnosis and treatment for a range of nasal and olfactory conditions, including long COVID-related anosmia.

We stay at the forefront of the latest medical advancements, including surgical options like functional septorhinoplasty (fSRP), to help patients regain their sense of smell and improve their quality of life.

Contact London ENT today at 0203 865 7225 to schedule a consultation and explore your treatment options.